DONALD ALTENBURG: Open Payments
NPI 1811225899 · BURNSVILLE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 19 payments from 16 companies in 2025. Trend: 2023 $396 · 2024 $355 · 2025 $484
Food & beverage: $334Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 3 | $163 |
| NS Pharma, Inc. | 1 | $39 |
| UCB, Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Neurelis, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Biogen, Inc. | 1 | $17 |
Products named: XYWAV, VILTEPSO, ULTOMIRIS, KESIMPTA, VALTOCO, Leqembi, Fintepla, Symbravo.
Industry payments across MN — which companies pay providers there.
